Cocrystal Pharma (COCP) Competitors $1.23 +0.01 (+0.41%) As of 01:29 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock COCP vs. ATNM, FGEN, BRNS, LTRN, PDSB, AADI, MDCX, NBRV, SCYX, and TELOShould you be buying Cocrystal Pharma stock or one of its competitors? The main competitors of Cocrystal Pharma include Actinium Pharmaceuticals (ATNM), FibroGen (FGEN), Barinthus Biotherapeutics (BRNS), Lantern Pharma (LTRN), PDS Biotechnology (PDSB), Aadi Bioscience (AADI), Medicus Pharma (MDCX), Nabriva Therapeutics (NBRV), SCYNEXIS (SCYX), and Telomir Pharmaceuticals (TELO). These companies are all part of the "pharmaceutical products" industry. Cocrystal Pharma vs. Its Competitors Actinium Pharmaceuticals FibroGen Barinthus Biotherapeutics Lantern Pharma PDS Biotechnology Aadi Bioscience Medicus Pharma Nabriva Therapeutics SCYNEXIS Telomir Pharmaceuticals Actinium Pharmaceuticals (NYSE:ATNM) and Cocrystal Pharma (NASDAQ:COCP) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability. Do analysts recommend ATNM or COCP? Actinium Pharmaceuticals currently has a consensus price target of $4.50, suggesting a potential upside of 187.54%. Cocrystal Pharma has a consensus price target of $6.00, suggesting a potential upside of 389.80%. Given Cocrystal Pharma's higher possible upside, analysts clearly believe Cocrystal Pharma is more favorable than Actinium Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Actinium Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Cocrystal Pharma 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more volatility and risk, ATNM or COCP? Actinium Pharmaceuticals has a beta of -0.25, suggesting that its stock price is 125% less volatile than the S&P 500. Comparatively, Cocrystal Pharma has a beta of 2.25, suggesting that its stock price is 125% more volatile than the S&P 500. Do institutionals and insiders hold more shares of ATNM or COCP? 27.5% of Actinium Pharmaceuticals shares are held by institutional investors. Comparatively, 6.7% of Cocrystal Pharma shares are held by institutional investors. 6.0% of Actinium Pharmaceuticals shares are held by insiders. Comparatively, 28.1% of Cocrystal Pharma shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media prefer ATNM or COCP? In the previous week, Cocrystal Pharma had 1 more articles in the media than Actinium Pharmaceuticals. MarketBeat recorded 1 mentions for Cocrystal Pharma and 0 mentions for Actinium Pharmaceuticals. Actinium Pharmaceuticals' average media sentiment score of 0.00 beat Cocrystal Pharma's score of -0.50 indicating that Actinium Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Actinium Pharmaceuticals Neutral Cocrystal Pharma Negative Which has preferable valuation & earnings, ATNM or COCP? Actinium Pharmaceuticals is trading at a lower price-to-earnings ratio than Cocrystal Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioActinium PharmaceuticalsN/AN/A-$48.82M-$1.31-1.19Cocrystal PharmaN/AN/A-$17.50M-$1.24-0.99 Is ATNM or COCP more profitable? Actinium Pharmaceuticals' return on equity of -100.85% beat Cocrystal Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Actinium PharmaceuticalsN/A -100.85% -47.89% Cocrystal Pharma N/A -144.12%-102.85% SummaryCocrystal Pharma beats Actinium Pharmaceuticals on 7 of the 13 factors compared between the two stocks. Get Cocrystal Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for COCP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding COCP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COCP vs. The Competition Export to ExcelMetricCocrystal PharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.58M$3.31B$6.12B$10.53BDividend YieldN/A2.29%5.51%4.67%P/E Ratio-0.9921.5685.7226.88Price / SalesN/A412.90581.25184.02Price / CashN/A46.3226.3031.10Price / Book1.3010.0213.226.67Net Income-$17.50M-$52.22M$3.30B$276.44M7 Day Performance-2.00%5.57%4.78%3.10%1 Month Performance-16.95%11.80%8.42%10.19%1 Year Performance-31.56%25.31%87.67%40.32% Cocrystal Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COCPCocrystal Pharma1.4598 of 5 stars$1.23+0.4%$6.00+389.8%-33.2%$12.58MN/A-0.9910ATNMActinium Pharmaceuticals2.0317 of 5 stars$1.62+0.6%$4.50+177.8%-12.8%$50.54MN/A-1.1730FGENFibroGen4.0722 of 5 stars$12.31flat$43.00+249.3%+23.4%$49.78M$29.62M-32.39570BRNSBarinthus Biotherapeutics2.3792 of 5 stars$1.48+21.3%$3.00+102.7%+18.0%$49.68M$14.97M-0.86107Gap UpHigh Trading VolumeLTRNLantern Pharma2.0617 of 5 stars$4.54+2.0%$25.00+450.7%+16.7%$48.11MN/A-2.5520PDSBPDS Biotechnology1.719 of 5 stars$1.01-1.0%$10.00+890.1%-74.1%$47.97MN/A-1.1020AADIAadi BioscienceN/A$1.94+2.6%N/A+1.0%$47.91M$25.07M-0.8540MDCXMedicus Pharma2.7496 of 5 stars$2.51-4.6%$23.50+836.3%N/A$46.86MN/A-1.87N/ANBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070SCYXSCYNEXIS0.6859 of 5 stars$1.05-2.3%N/A-45.3%$45.07M$3.75M-2.6260TELOTelomir Pharmaceuticals3.2487 of 5 stars$1.34-3.6%$15.00+1,019.4%-73.8%$44.87MN/A-2.481News CoveragePositive NewsShort Interest ↓Gap Up Related Companies and Tools Related Companies ATNM Competitors FGEN Competitors BRNS Competitors LTRN Competitors PDSB Competitors AADI Competitors MDCX Competitors NBRV Competitors SCYX Competitors TELO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:COCP) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cocrystal Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cocrystal Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
